Apomorphine and schizophrenia

C. A. Johns; M. I. Levy; B. M. Davis; R. C. Mohs; K. S. Kendler; A. A. Mathe; G. Trigos; T. B. Horvath; K. L. Davis

Apomorphine and schizophrenia

C. A. Johns
, M. I. Levy
, B. M. Davis
, R. C. Mohs
, K. S. Kendler
, A. A. Mathe
, G. Trigos
, T. B. Horvath
, K. L. Davis

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Low-dose apomorphine did not improve schizophrenic symptoms or TD in patients with various clinical states of schizophrenia, despite neurochemical and neuroendocrine verification that apomorphine did have a central nervous system effect. Future studies of various doses of apomorphine given with various neuroleptics of differing classes may help determine if such a combination might have more beneficial, synergistic effects.

Original language	English
Pages (from-to)	103-107
Number of pages	5
Journal	Psychopharmacology Bulletin
Volume	20
Issue number	1
State	Published - 1984

Cite this

@article{97118ebb3a904ddb94283d0d88b70c91,

title = "Apomorphine and schizophrenia",

abstract = "Low-dose apomorphine did not improve schizophrenic symptoms or TD in patients with various clinical states of schizophrenia, despite neurochemical and neuroendocrine verification that apomorphine did have a central nervous system effect. Future studies of various doses of apomorphine given with various neuroleptics of differing classes may help determine if such a combination might have more beneficial, synergistic effects.",

author = "Johns, \{C. A.\} and Levy, \{M. I.\} and Davis, \{B. M.\} and Mohs, \{R. C.\} and Kendler, \{K. S.\} and Mathe, \{A. A.\} and G. Trigos and Horvath, \{T. B.\} and Davis, \{K. L.\}",

year = "1984",

language = "English",

volume = "20",

pages = "103--107",

journal = "Psychopharmacology Bulletin",

issn = "0048-5764",

publisher = "MedWorks Media LLC",

number = "1",

}

TY - JOUR

T1 - Apomorphine and schizophrenia

AU - Johns, C. A.

AU - Levy, M. I.

AU - Davis, B. M.

AU - Mohs, R. C.

AU - Kendler, K. S.

AU - Mathe, A. A.

AU - Trigos, G.

AU - Horvath, T. B.

AU - Davis, K. L.

PY - 1984

Y1 - 1984

N2 - Low-dose apomorphine did not improve schizophrenic symptoms or TD in patients with various clinical states of schizophrenia, despite neurochemical and neuroendocrine verification that apomorphine did have a central nervous system effect. Future studies of various doses of apomorphine given with various neuroleptics of differing classes may help determine if such a combination might have more beneficial, synergistic effects.

AB - Low-dose apomorphine did not improve schizophrenic symptoms or TD in patients with various clinical states of schizophrenia, despite neurochemical and neuroendocrine verification that apomorphine did have a central nervous system effect. Future studies of various doses of apomorphine given with various neuroleptics of differing classes may help determine if such a combination might have more beneficial, synergistic effects.

UR - https://www.scopus.com/pages/publications/0021139039

M3 - Article

C2 - 6718635

AN - SCOPUS:0021139039

SN - 0048-5764

VL - 20

SP - 103

EP - 107

JO - Psychopharmacology Bulletin

JF - Psychopharmacology Bulletin

IS - 1

ER -

Apomorphine and schizophrenia

Abstract

Fingerprint

Cite this